Free Delivery Over $100
|
|
|||
|
||||
OverviewFull Product DetailsAuthor: David Green (Professor of Medicine Emeritus, Northwestern University Feinberg School of Medicine, Chicago, IL, USA)Publisher: Elsevier Science Publishing Co Inc Imprint: Academic Press Inc Weight: 0.410kg ISBN: 9780128187814ISBN 10: 0128187816 Pages: 214 Publication Date: 10 November 2020 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand  We will order this item for you from a manufactured on demand supplier. Table of ContentsPart I. Historical Development and Properties 1. Anticoagulant Heparins 2. Non-anticoagulant Heparins Part II. Clinical Applications 3. Prevention of Thrombosis 4. Therapy for Thrombosis Part III. Adverse Effects 5. Bleeding, heparin-induced thrombocytopeniaReviews"""This is a useful addition to the library of hematologists, internists, pathologists, and other clinicians who use anticoagulant therapy. It is a helpful reference for the history of drug development and clinical trials in this area of medicine. Although many textbooks of hematology and internal medicine will contain some of this information, I am not aware of another recent book with this comprehensive focus."" --Doody" This is a useful addition to the library of hematologists, internists, pathologists, and other clinicians who use anticoagulant therapy. It is a helpful reference for the history of drug development and clinical trials in this area of medicine. Although many textbooks of hematology and internal medicine will contain some of this information, I am not aware of another recent book with this comprehensive focus. --Doody Author InformationDr. Green is a hematologist with 45 years of clinical & research experience and an expert on hemostasis and thrombosis. He teaches medical students, interns, residents, fellows, and practicing physicians and has organized symposia, given national and international presentations, and published extensively on bleeding and clotting disorders. His lectures to medical students on anticoagulant therapy have garnered teaching awards, and he has been a co-investigator on landmark clinical trials of heparin and low molecular weight heparin. He is the author or co-author of two dozen publications devoted to heparins, including 19 peer-reviewed research papers in major medical journals. He is also the author of two recent books, Linked by Blood: Hemophilia and AIDS, and Factor VIII and Von Willebrand Factor. Tab Content 6Author Website:Countries AvailableAll regions |
||||
